Trials / Terminated
TerminatedNCT03959072
Cardiac Cath Lab Staff Radiation Exposure
Cardiac Cath Lab Staff Radiation Exposure During Chronic Total Occlusion PCI: CorPath GRX vs. Manual
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 74 (actual)
- Sponsor
- Corindus Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The objective of this randomized safety and observational study is to demonstrate CorPath GRX chronic total occlusion PCI is safe, and that Cardiac Catheterization Laboratory staff have no additional exposure to radiation when compared to conventional manual chronic total occlusion PCI procedures without added procedure time.
Detailed description
This is prospective, dual-arm, randomized, multi-center, observational study comparing patient outcomes and staff radiation exposure in chronic total occlusion PCI procedures through 48 hours post procedure or hospital discharge, whichever occurs first.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Robotic CTO PCI | Randomized to robotic CTO PCI. |
| PROCEDURE | Conventional (Manual) CTO PCI | Randomized to manual CTO PCI. |
Timeline
- Start date
- 2019-09-05
- Primary completion
- 2021-09-14
- Completion
- 2021-09-15
- First posted
- 2019-05-22
- Last updated
- 2023-02-02
Locations
3 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03959072. Inclusion in this directory is not an endorsement.